These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 23866969

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
    Lane DA, Wood K.
    Circulation; 2015 Apr 21; 131(16):e412-5. PubMed ID: 25901074
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 21; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 5. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
    Tran H, Joseph J, Young L, McRae S, Curnow J, Nandurkar H, Wood P, McLintock C.
    Intern Med J; 2014 Jun 21; 44(6):525-36. PubMed ID: 24946813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B, Faille D, Ajzenberg N.
    Med Sci (Paris); 2011 May 21; 27(5):493-500. PubMed ID: 21609670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
    Klauser W, Dütsch M.
    Musculoskelet Surg; 2013 Dec 21; 97(3):189-97. PubMed ID: 24249360
    [Abstract] [Full Text] [Related]

  • 10. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug 21; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel oral anticoagulants--key messages for the angiologist.
    Haas S, Spannagl M, Schellong SM.
    Vasa; 2012 May 21; 41(3):177-91. PubMed ID: 22565619
    [Abstract] [Full Text] [Related]

  • 20. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists.
    Levy JH.
    Clin Lab Med; 2014 Sep 21; 34(3):443-52. PubMed ID: 25168936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.